You have 9 free searches left this month | for more free features.

HS-20105

Showing 1 - 25 of 549

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial (HS-20105)

Not yet recruiting
  • Advanced Solid Tumor
  • HS-20105
  • (no location specified)
Nov 17, 2023

s to Diagnose Acute Myocardial Infarction in Elevated Hs-cTnT

Completed
  • Acute Myocardial Infarction
  • No Intervention
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 26, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Renal Cell Carcinoma Trial (HS-10516)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 24, 2023

Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)

Not yet recruiting
  • Psoriasis
  • HS-10374 tablets 1mg
  • +2 more
  • Shanghai, Shanghai, China
    Huashan Hospital of Fudan University
Oct 8, 2023

Overweight and Obesity Trial in Harbin (HS-20094, Placebo)

Recruiting
  • Overweight and Obesity
  • Harbin, Heilongjiang, China
  • +1 more
Nov 3, 2023

Advanced Solid Tumor Trial (HS-20093)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 29, 2023

HIDRAdenitis Suppurativa and HEART Disease

Enrolling by invitation
  • Hidradenitis
  • +10 more
    • Hellerup, Copenhagen, Denmark
      Department of Cardiology, Herlev and Gentofte University Hospita
    Aug 4, 2023

    Hidradenitis Suppurativa Trial in Minneapolis (Fecal Microbiota - lyophilized, Placebo drug)

    Not yet recruiting
    • Hidradenitis Suppurativa
    • Fecal Microbiota - lyophilized
    • Placebo drug
    • Minneapolis, Minnesota
      University of Minnesota
    Oct 2, 2023

    Switching From Cardiac Troponin I to T

    Recruiting
    • Acute Coronary Syndrome
    • +5 more
    • Clinical implementation of hs-cTnT
    • Edinburgh, United Kingdom
      Centre for Cardiovascular Science
    Feb 17, 2023

    NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • HS-10241+ Almonertinib
    • Pemetrexed + Cisplatin /Carboplatin
    • (no location specified)
    Oct 29, 2023

    NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Solid Tumor
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 10, 2023

    Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

    Not yet recruiting
    • Metastasis Castration Resistant Prostate Cancer(mCRPC)
    • (no location specified)
    Aug 14, 2023

    Hidradenitis Suppurativa, Acne Inversa Trial (Nd:YAG laser hair removal, Clindamycin 1 % Topical Lotion)

    Not yet recruiting
    • Hidradenitis Suppurativa, Acne Inversa
    • Nd:YAG laser hair removal
    • Clindamycin 1 % Topical Lotion
    • (no location specified)
    Feb 28, 2023

    Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Aug 17, 2023

    Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)

    Recruiting
    • Type 2 Diabetes
    • HS-20094 5mg
    • +3 more
    • Beijing, Beijing, China
      Peking University First Hospital
    Nov 3, 2023

    Endometriosis Trial (HS-10518, Placebo)

    Not yet recruiting
    • Endometriosis
    • (no location specified)
    Nov 1, 2023

    Vasomotor Symptoms Trial in Peking (HS-10384 tablets, HS-10384-matched tablets)

    Not yet recruiting
    • Vasomotor Symptoms
    • HS-10384 tablets
    • HS-10384-matched placebo tablets
    • Peking, Beijing, China
      Peking University Third Hospital
    Nov 7, 2023

    Hidradenitis Suppurativa Trial in Detroit (Laight therapy, NICE V3.1 device)

    Completed
    • Hidradenitis Suppurativa
    • Laight therapy, NICE V3.1 device
    • Detroit, Michigan
      Henry Ford Hospital Systems- New Center One
    Jun 28, 2023

    Psoriasis Trial in Shanghai (HS-10374 tablets, HS-10374-matched tablets)

    Completed
    • Psoriasis
    • HS-10374 tablets
    • HS-10374-matched placebo tablets
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Sep 5, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Beijing, Beijing, China
      Lingying Wu
    Aug 22, 2023

    Hidradenitis Suppurativa Trial in Little Rock (Mindfulness Based Stress reduction)

    Recruiting
    • Hidradenitis Suppurativa
    • Mindfulness Based Stress reduction
    • Little Rock, Arkansas
      UAMS Dermatology Clinic
    Nov 2, 2023

    Cough Trial in Jinan (HS-10383, HS-10383 Placebo)

    Recruiting
    • Cough
    • Jinan, Shandong, China
      Shandong provincial qianfoshan hospital
    Oct 19, 2023

    Genetic Traits and Linkages in Families

    Recruiting
    • Hidradenitis Suppurativa
      • Chicago, Illinois
        University of Chicago Medicine
      Jan 25, 2023

      Hidradenitis Suppurativa, Quality of Life Trial in Miami (Mindfulness Course, HS Educational Course)

      Not yet recruiting
      • Hidradenitis Suppurativa
      • Quality of Life
      • Mindfulness Course
      • HS Educational Course
      • Miami, Florida
        University of Miami
      Jan 18, 2023